论文部分内容阅读
目的:观察普米克令舒与博利康尼雾化液联合应用治疗儿童哮喘急性发作的疗效。方法:随机将本院儿科2006年1月至2007年6月收治的130例儿童哮喘急性发作患儿分为两组。实验组68例,给予普米克令舒与博利康尼雾化液雾化吸入治疗;对照组62例,予以氨茶碱、地塞米松等静脉滴注解痉平喘及吸氧等对症支持治疗。通过观察咳嗽、喘息和肺部哮鸣音的变化情况判定疗效。结果:实验组咳嗽、喘息和肺部哮鸣音持续时间均效对照组明显缩短(P<0.01);两组疗效比较差异有显著意义(P=0.00)。结论:普米克令舒与博利康尼雾化液联合应用治疗儿童哮喘急性发作具有较强的快速抗炎作用和缓解症状的疗效。
Objective: To observe the curative effect of Pulmicort respules with Boli Kang Ni atomized liquid in the treatment of acute attack of childhood asthma. Methods: A total of 130 children with acute asthma exacerbation who were admitted to our hospital from January 2006 to June 2007 were randomly divided into two groups. In the experimental group, 68 cases were treated with atomization inhalation of pulmicort respules and boliconi. In the control group, 62 cases were treated with intravenous infusion of aminophylline and dexamethasone for antispasmodic and antiasthmatic effects and oxygen inhalation. By observing the cough, wheezing and lung wheeze changes in the situation to determine the efficacy. Results: The average cough, wheezing and wheezing duration of the lungs in the experimental group were significantly shorter than those in the control group (P <0.01). There was significant difference between the two groups (P = 0.00). Conclusion: Pulmicort respules combined with atomization of Boli Kang Ni in the treatment of children with acute asthma attack have strong fast anti-inflammatory effect and relieve symptoms.